Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
West Pharmaceutical Services, Inc. Financials Banner

West Pharmaceutical Services, Inc. Financials

WST Stock Analysis

Page title

Section title

WST Income Statement Key Metrics

  • Revenue(TTM)2.88 B
  • Gross Profit(TTM)1.03 B
  • EBITDA(TTM)760.70 M
  • Net Income(TTM)524.90 M
  • EPS Diluted(TTM)7.030000000000001

Decode WST's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

WST earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of WST (0.383) is lower than the average of its peers (0.497).

Net Profit Margin vs Peers

Net profit margin ratio of WST (0.201) is higher than the average of its peers (0.097).

WST Return on Equity

See how efficiently WST generates profit for it's shareholders.

20.60%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of WST (0.206) is higher than the average of its peers (0.080).

Return on Equity Growth

WST's Return on Equity has shown poor growth over the past 10 years, increasing by only 4.48%.

WST Revenue Growth

See how WST has grown it's revenue over the past 10 years.


Revenue Growth

WST's revenue has shown poor growth over the past 10 years, increasing by only 7.57%.

WST FY, 2023 Revenue Breakdown

See how WST converts it's revenue into profit.

WST Balance Sheet Health

WST Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

WST financial position analysis

Short Term Liabilities

WST's short term assets($2B) can safely cover it's short term liabilities($672M).

Long Term Liabilities

WST's short term assets($2B) can safely cover it's long term liabilities($277M).

WST Debt to Equity